Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

Table 2 Multiple non-inferiority analysis for Hp eradication rates

	Group	Eradication rate And 95% CI (ITT)	Eradication rate And 95% CI (PP)	Difference [95% CI] (ITT)	Difference [95% CI] (PP)	P ^†
V1 and V2	V1	84.4% 73.4–95.5%	88.4% 78.4–98.4%	−14.9-14.9%	−8.2-16.8%	0.095(ITT) 0.186(PP)
V1 and V2	V2	84.4% 73.4–95.5%	92.7% 84.4–101.0%	−14.9-14.9%	−8.2-16.8%	0.095(ITT) 0.186(PP)
V3 AndV2	V3	84.4% 73.4–95.5%	88.4% 78.4–98.4%	−14.9-14.9%	−8.2-16.8%	0.095(ITT) 0.186 (PP)
V3 AndV2	V2	84.4% 73.4–95.5%	92.7% 84.4–101.0%	−14.9-14.9%	−8.2-16.8%	0.095(ITT) 0.186 (PP)

ISSN: 1471-230X